Otipax (Phenazone, Lidocaine Hydrochloride)

Phenazone, the active ingredient in Otipax, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as a topical ear formulation for local ear pain relief. It is combined with lidocaine hydrochloride, a local anesthetic, to provide symptomatic relief in otic conditions. GNH USA supplies Otipax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otipax is used in the management of ear discomfort through its anti‑inflammatory and local‑anesthetic actions. - Acute otitis media: reduces pain and inflammation in the middle ear. - External ear canal irritation: alleviates burning and itching associated with mild otitis externa. - Post‑procedural ear pain: provides symptomatic relief after ear examinations or minor procedures.

Adverse reactions may occur following topical application of Otipax.

Common Side Effects: - Mild itching or burning sensation at the application site. - Temporary ear fullness or a feeling of pressure. - Minor redness of the external ear canal.

Serious or Rare Side Effects: - Allergic contact dermatitis with swelling or vesicle formation. - Persistent otitis media or secondary infection. - Severe ototoxicity leading to hearing changes. - Systemic hypersensitivity reactions such as urticaria or anaphylaxis.

When using Otipax, consider the following safety measures: - Contraindication: Do not use in patients with known allergy to phenazone, lidocaine or any formulation excipients. - Assessment: Evaluate the presence of ear perforation before application. - Monitoring: Observe for signs of local irritation or infection. - Interaction: Avoid simultaneous use of other topical otologic preparations. - Storage: Store at below 25°C: keep in the original pack and protect from moisture.

Oti­pax ​​  ​    ​      ​  … …  … …  …  …  …  … … … …  …  …  …  ​  

Major Interaction :      t   g  g  ewline  ewline \n    ewline  ".  "  "  g  ewline  ewline